		Technical Data
C9100-21N1	Cytomegalovirus Glycoprotein B, Late Neutralizing Antigen (CMV gB, CMV Glycoprotein GP55, HCMV, Human Herpesvirus 5, HHV-5, HHV5, UL55) (FITC)

Description:
Glycoprotein B (gB) is the main antigenic protein within the envelope of HCMV. It is required for HCMV mediated membrane fusion along with the gH / gL complex. The unprocessed precursor of HCMV gB is 906 amino acids in length, with a MW of approximately 100kDa.

Applications:
Suitable for use in Immunofluorescence. Other applications not tested.

Recommended Dilution:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4°C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and store at -20°C. Aliquots are stable for at least 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. FITC conjugates are sensitive to light.

Type	Isotype	Clone	Grade
Mab	IgG2a	10B2664	Affinity Purified

Size		Storage	Shipping	Source	Host
100ug		-20°C	Blue Ice		Mouse

Concentration:

~0.1mg/ml

Immunogen:

Human CMV extracts.

Purity:

Purified by Protein G affinity chromatography.

Form

Supplied as a liquid in PBS, pH 7.4, 1% BSA, 0.09% sodium azide. Labeled with fluorescein isothiocyanate (FITC).

Specificity:

Recognizes Cytomegalovirus glycoprotein B late neutralizing antigen. Cytomegalovirus is an enveloped double stranded DNA virus which in humans (HCMV) is commonly known as human herpesvirus 5 (HHV-5). Reacts with MRC-5 infected cells but not uninfected cells. This antibody has been found to be neutralizing.

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.